Don’t miss out! Book your tickets to our Business Lunch
🗣️ Guest speaker: @profalanboyd, the founder of @boydconsultants - the global drug development consultancy in Crewe
🍽️ Delicious meal included
📍 Location: Rookery Hall Hotel & Spa
Tickets: https://t.co/4HYtgfLaa0
This Tuesday at 18.15 join for our in person talk by Prof Alan Boyd about botanical origins of pharmaceutical medicines.
Pre-talk:17.45
Post-talk:19.15 in Nyholm room.
You can register to our event through Eventbrite.
Location: XLG1, CIB
@UCLChemistry#ucl#chemistry#stem
For biotech and life sciences companies, entering into a deal can feel risky and uncertain. Boyds explains how scientific due diligence can mitigate those risks, and ensure there are no surprises when the deal is done.
Read more: https://t.co/qOcYuR6sFZ
We are delighted to announce the appointment of experienced regulatory affairs professional and cell and gene therapy expert, Dr Patrick Ginty.
https://t.co/crTFpXBSE7
The November Regulatory Intelligence Digest is here. Keep up to date with all the latest from the Regulatory Agencies - FDA, EMA, EC & MHRA. - https://t.co/PFyNh5mMPy
On Thursday 1 December, Professor Alan Boyd is delivering a special lecture at the Royal Society of Chemistry in partnership with the Faculty of Pharmaceutical Medicine - Botanical Origins of Pharmaceutical Medicine.
For more details: https://t.co/BiLriP9qSQ
Together with our partners in the Clinical Pharmacology Skills Alliance (CPSA), we are calling for investment in UK #ClinicalPharmacology for healthier patients, better medicines and a more efficient NHS.
Read more: https://t.co/NFiVKEBFKr
#ClinPharmWeek
Why is obtaining expert medical input early on during study set-up processes so critical?
Read our latest blog 'Medical Monitors in Clinical Trials: the linchpin between patients and sponsors' 🥼 : https://t.co/w2NTyfRiVf
The Regulatory Intelligence Digest for September 2022 is here. Keep up to date with all the latest from the Regulatory Agencies - FDA, EMA, EC, MHRA, HRA, ICH & FPM. Read here: - https://t.co/lt81pwkMo7
We are delighted to announce the appointment of Chris Moore as Clinical Project Manager at Boyds to support growing demand for our specialist clinical trial expertise.
Read more: https://t.co/ugKdnYHqPK
#PROs can provide valuable info on long-term effectiveness, safety/tolerability of treatment. Want to know more on use #PROs in real-world evidence- check out our Analysis of https://t.co/xNp4hqPOxm … https://t.co/CwXENjsLaH @KonradMaruszczy@lee_1881@TJHKeeley@PhilipCollis
The Academy elects new Vice-Chairs: we are pleased to announce that Dr Fiona Donald @RCoAPresident@RCoANews and Mr @MikeMckirdy@rcpsglasgow have been elected Vice-Chairs. https://t.co/Iq8woeMgd0
🧬Boyds has a proven track record in supporting the development of ATMPs, and of the 21 approved products on the market today, Boyds has worked on 8 of them at some time.
Find out how the Boyds team can support you on your drug development journey: https://t.co/e2emXVqYZh
This @FutureHealthJ article gives a concise overview of the joint #PersonalisedPrescribing report published March 2022 by us and @RCPhysicians. It explains how implementing #pharmacogenomics into the NHS can improve prescribing practices and safety.
Read: https://t.co/awXoMOdyBq